-
1
-
-
77949426782
-
Molecular biology of Hodgkin lymphoma
-
PMID:20008234
-
Küppers R. Molecular biology of Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 2009; 1:491-6; PMID:20008234; http://dx.doi.org/10.1182/ asheducation-2009.1.491
-
(2009)
Hematology Am Soc Hematol Educ Program
, vol.1
, pp. 491-496
-
-
Küppers, R.1
-
2
-
-
4744367613
-
Tumour escape from the immune response
-
PMID:15185008
-
Pawelec G. Tumour escape from the immune response. Cancer Immunol Immunother 2004; 53:843; PMID:15185008; http://dx.doi.org/10.1007/s00262-004-0531-y
-
(2004)
Cancer Immunol Immunother
, vol.53
, pp. 843
-
-
Pawelec, G.1
-
3
-
-
84872532787
-
Expression of CD137 on Hodgkin and Reed-Sternberg cells inhibits T-cell activation by eliminating CD137 ligand expression
-
PMID:23204227
-
Ho WT, Pang WL, Chong SM, Castella A, Al-Salam S, Tan TE, et al. Expression of CD137 on Hodgkin and Reed-Sternberg cells inhibits T-cell activation by eliminating CD137 ligand expression. Cancer Res 2013; 73:652-61; PMID:23204227; http://dx.doi. org/10.1158/0008-5472.CAN-12-3849
-
(2013)
Cancer Res
, vol.73
, pp. 652-661
-
-
Ho, W.T.1
Pang, W.L.2
Chong, S.M.3
Castella, A.4
Al-Salam, S.5
Tan, T.E.6
-
4
-
-
84865215820
-
CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications
-
PMID:22901750
-
Anderson MW, Zhao S, Freud AG, Czerwinski DK, Kohrt H, Alizadeh AA, et al. CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications. Am J Pathol 2012; 181:795-803; PMID:22901750; http://dx.doi.org/10.1016/j. ajpath.2012.05.015
-
(2012)
Am J Pathol
, vol.181
, pp. 795-803
-
-
Anderson, M.W.1
Zhao, S.2
Freud, A.G.3
Czerwinski, D.K.4
Kohrt, H.5
Alizadeh, A.A.6
-
5
-
-
63849254074
-
CD137, implications in immunity and potential for therapy
-
PMID:19273343
-
Thum E, Shao Z, Schwarz H. CD137, implications in immunity and potential for therapy. Front Biosci 2009; 14:4173-88; PMID:19273343; http://dx.doi. org/10.2741/3521
-
(2009)
Front Biosci
, vol.14
, pp. 4173-4188
-
-
Thum, E.1
Shao, Z.2
Schwarz, H.3
-
6
-
-
84862487155
-
Recombinant human CD137L for cancer immunotherapy: effects of different fusions and linkers on its activity
-
PMID:21968735
-
Wang S, Lv J, Wang P, Yin X, Tan A, Chen Y. Recombinant human CD137L for cancer immunotherapy: effects of different fusions and linkers on its activity. Cancer Immunol Immunother 2011; 4:489-95; PMID:21968735
-
(2011)
Cancer Immunol Immunother
, vol.4
, pp. 489-495
-
-
Wang, S.1
Lv, J.2
Wang, P.3
Yin, X.4
Tan, A.5
Chen, Y.6
-
7
-
-
0033560179
-
4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine
-
PMID:10202049
-
Guinn BA, DeBenedette MA, Watts TH, Berinstein NL. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine. J Immunol 1999; 162:5003-10; PMID:10202049
-
(1999)
J Immunol
, vol.162
, pp. 5003-5010
-
-
Guinn, B.A.1
DeBenedette, M.A.2
Watts, T.H.3
Berinstein, N.L.4
-
8
-
-
49449108720
-
Characterisation of soluble murine CD137 and its association with systemic lupus
-
PMID:18640726
-
Shao Z, Sun F, Koh DR, Schwarz H. Characterisation of soluble murine CD137 and its association with systemic lupus. Mol Immunol 2008; 45:3990-9; PMID:18640726; http://dx.doi.org/10.1016/j. molimm.2008.05.028
-
(2008)
Mol Immunol
, vol.45
, pp. 3990-3999
-
-
Shao, Z.1
Sun, F.2
Koh, D.R.3
Schwarz, H.4
-
9
-
-
18644383814
-
Levels of soluble CD137 are enhanced in sera of leukemia and lymphoma patients and are strongly associated with chronic lymphocytic leukemia
-
Leukemia Research Fund, UK.
-
Furtner M, Straub RH, Kruger S, Schwarz H. Levels of soluble CD137 are enhanced in sera of leukemia and lymphoma patients and are strongly associated with chronic lymphocytic leukemia. Leukemia: official journal of the Leukemia Society of America. Leukemia Research Fund, UK 2005; 19:883-5; http://dx.doi. org/10.1038/sj.leu.2403675
-
(2005)
Leukemia: official journal of the Leukemia Society of America.
, vol.19
, pp. 883-885
-
-
Furtner, M.1
Straub, R.H.2
Kruger, S.3
Schwarz, H.4
-
10
-
-
84872862122
-
CD137 Ligand Is expressed in primary and secondary lymphoid follicles and in B-cell lymphomas: diagnostic and therapeutic implications
-
PMID:23095505
-
Zhao S, Zhang H, Xing Y, Natkunam Y. CD137 Ligand Is expressed in primary and secondary lymphoid follicles and in B-cell lymphomas: diagnostic and therapeutic implications. Am J Surg Pathol 2013; 37:250-8; PMID:23095505; http://dx.doi. org/10.1097/PAS.0b013e318268c6ea
-
(2013)
Am J Surg Pathol
, vol.37
, pp. 250-258
-
-
Zhao, S.1
Zhang, H.2
Xing, Y.3
Natkunam, Y.4
|